• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 4. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 5. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088

Introduction to (+)-Norfenfluramine Hydrochloride (CAS No. 37936-89-3)

(+)-Norfenfluramine hydrochloride, with the chemical identifier CAS No. 37936-89-3, is a compound of significant interest in the field of pharmaceutical chemistry and pharmacology. This compound, a hydrochloride salt, has garnered attention due to its structural similarity to certain psychoactive agents and its potential applications in biochemical research. The stereochemistry of (+)-Norfenfluramine hydrochloride, specifically the presence of the (R) configuration at the chiral center, plays a crucial role in its pharmacological properties, distinguishing it from its enantiomer and other related molecules.

The molecular structure of (+)-Norfenfluramine hydrochloride consists of a phenethylamine core, which is a common scaffold in many psychoactive substances. This core structure contributes to its interaction with various neurotransmitter systems in the central nervous system. The hydrochloride form enhances the solubility of the compound, making it more suitable for formulation in pharmaceutical preparations and biological assays.

Recent research has explored the pharmacological profile of (+)-Norfenfluramine hydrochloride, particularly its effects on serotonin and norepinephrine reuptake mechanisms. Studies have indicated that this compound may exhibit anorectic properties, similar to its parent compound fenfluramine, though with potentially reduced cardiovascular side effects. The mechanism of action involves modulation of neurotransmitter levels in key brain regions involved in appetite regulation and mood control.

One of the most compelling aspects of (+)-Norfenfluramine hydrochloride is its utility as a research tool. Its well-defined stereochemistry and pharmacological activity make it an invaluable compound for studying the role of enantiomers in drug development. Researchers utilize (+)-Norfenfluramine hydrochloride to investigate the relationship between molecular structure and biological activity, which is fundamental to rational drug design.

In addition to its pharmacological applications, (+)-Norfenfluramine hydrochloride has been employed in biochemical assays to probe the function of transporters and receptors involved in neurotransmitter homeostasis. These studies contribute to a deeper understanding of neurological disorders and the development of targeted therapies. The compound's ability to interact with specific binding sites provides insights into the pathophysiology of conditions such as depression, anxiety, and eating disorders.

The synthesis of (+)-Norfenfluramine hydrochloride is a topic of considerable interest in synthetic organic chemistry. The stereocontrolled preparation of this compound requires sophisticated methodologies to ensure high enantiomeric purity. Advances in asymmetric synthesis have enabled more efficient and scalable production processes, making (+)-Norfenfluramine hydrochloride more accessible for both academic and industrial research purposes.

From a regulatory perspective, (+)-Norfenfluramine hydrochloride is subject to standard guidelines for pharmaceutical compounds, ensuring that its production, handling, and use comply with safety and quality standards. While not classified as a controlled substance in many jurisdictions, researchers must adhere to ethical guidelines and institutional review board approvals when conducting experiments involving this compound.

The future directions for research on (+)-Norfenfluramine hydrochloride are promising, with investigations focusing on optimizing its therapeutic index and minimizing potential side effects. By leveraging computational modeling and high-throughput screening techniques, scientists aim to develop derivatives with enhanced efficacy and safety profiles. These efforts align with broader trends in medicinal chemistry aimed at creating next-generation treatments for neurological and metabolic disorders.

In summary, (+)-Norfenfluramine hydrochloride (CAS No. 37936-89-3) represents a significant compound in pharmaceutical research due to its unique structural features, pharmacological properties, and utility as a tool for understanding neurotransmitter systems. Its continued study promises to contribute valuable insights into both basic science and therapeutic development.

• 83616-19-7(Benzeneethanamine, alpha-propyl-3-(trifluoromethyl)-, (+-)-)
• 1081-78-3(2-Methyl-1-4-(trifluoromethyl)phenylpropan-2-amine Hydrochloride)
• 1886-26-6(Desethyl Fenfluramine)
• 37577-22-3((2R)-1-3-(trifluoromethyl)phenylpropan-2-amine)
• 1626-74-0(2-Amino-1-4-(trifluoromethyl)phenylpropane)
• 19036-73-8((2S)-1-3-(trifluoromethyl)phenylpropan-2-amine)
• 673-18-7(Norfenfluramine)
• 74051-20-0(Benzeneethanamine, a-ethyl-3-(trifluoromethyl)-)
• 89763-80-4(Benzeneethanamine, a-ethyl-4-(trifluoromethyl)-)
• 89763-79-1(Benzeneethanamine, α-ethyl-4-(trifluoromethyl)-, hydrochloride (1:1))